Role of transporters in drug interactions (Q37964577)

26 August 2017

title

Role of transporters in drug interactions (English)

1 reference

26 August 2017

Hyo-Kyung Han

1

1 reference

26 August 2017

publication date

1 November 2011

1 reference

Archives of Pharmacal Research

26 August 2017

published in

1 reference

26 August 2017

volume

34

1 reference

26 August 2017

issue

11

1 reference

26 August 2017

page(s)

1865-1877

1 reference

P-glycoprotein: from genomics to mechanism.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Fruit juice inhibition of uptake transport: a new type of food-drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Transport of cimetidine by flounder and human renal organic anion transporter 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

In Vitro and In Vivo Evidence of the Importance of Organic Anion Transporters (OATs) in Drug Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Potential of pharmacokinetic profiling for detecting herbal interactions with drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Drug-associated renal dysfunction and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Membrane transporters in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The superfamily of organic anion transporting polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The effect of rifampin administration on the disposition of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Drug-drug interaction between pitavastatin and various drugs via OATP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Interaction of imatinib with human organic ion carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Cyclosporine markedly raises the plasma concentrations of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Impact of OATP transporters on pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Dose-dependence of the nifedipine-digoxin interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Effects of orange juice on the pharmacokinetics of atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Therapeutic implications of renal anionic drug transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Flavonoid-drug interactions: effects of flavonoids on ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Gemfibrozil considerably increases the plasma concentrations of rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Role of OATP transporters in the disposition of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

MDR- and CYP3A4-mediated drug-herbal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

P-glycoprotein recognition of substrates and circumvention through rational drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Pharmacokinetics of cephradine given intravenously with and without probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Grapefruit juice ingestion significantly reduces talinolol bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Grapefruit-drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug inter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Organic anion transporting polypeptides (OATPs): regulation of expression and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Herb-drug pharmacokinetic interactions reviewed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Effect of St John's wort on the pharmacokinetics of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Drug interactions evaluation: an integrated part of risk assessment of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

Herbal modulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12272-011-1107-Y

10.1007/S12272-011-1107-Y

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference